Interventional oncology is an emerging and rapidly growing offshoot of interventional radiology, which emphasizes on the use of minimally-invasive procedures for the diagnosis, treatment, and palliative care for cancer patients. It uses image-guided technologies such as CT, fluoroscopy or ultrasound to target tumor lesions by making small puncture in the skin. Interventional oncology is generally meant for patients who are not able to respond positively towards the chemotherapy or radiation, or ones are unable to undergo surgery.
The global Interventional Oncology Market is expected to grow at a CAGR of 7.7% from 2019 to 2025 to reach $1,506.3 million by 2025.
Here are the Top 10 Companies in Interventional Oncology :
Boston Scientific Corporation (U.S.)
Founded in 1979 and headquartered at Massachusetts, the U.S.; Boston Scientific Corporation (U.S.) is a developer, manufacturer, and marketer of medical devices used in a broad range of interventional medical specialties. The company operates through three business segments namely Cardiovascular, Rhythm and Neuro, and MedSurg. The company provides interventional oncology products under the cardiovascular business segment. In cardiovascular business segment, the company provides technologies for diagnosing and treating coronary artery diseases, and other cardiovascular disorders including structural heart conditions under two sub-segments namely Interventional Cardiology and Peripheral Interventions. The Peripheral Interventions division offers devices used in peripheral angioplasty and peripheral vascular diseases along with interventional oncology products like peripheral embolization devices, microcatheters, and drainage catheters.
With its subsidiaries and strong network of distribution, the company has its presence in various regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The major subsidiaries of Boston Scientific Corporation are American Medical Systems Inc. (U.S.), Cameron Health, Inc. (U.S.), Boston Scientific Japan K.K. (Japan), and more.
Cook Medical LLC
Founded in 1963 and headquartered at Indiana, the U.S.; Cook Medical LLC is a manufacturer of minimally invasive medical devices. The company provides medical devices for 41 medical specialities including diagnostic radiology, endourology, gynecology, interventional radiology, obstetrics, and more. The company has two business divisions namely vascular and MedSurg. The company provides interventional oncology products under the vascular division. With its subsidiaries and strong network of distributors, the company has its presence across 135 countries.
The major subsidiaries of the company include Cook MyoSite Incorporated (U.S.) and Cook Urology (U.S.).
Merit Medical Systems, Inc.
Founded in 1987 and headquartered at Utah, the U.S.; Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used across various therapeutic areas like cardiology, radiology, oncology, critical care, and endoscopy for the diagnosis, treatment therapy, and surgical intervention procedures. The company offer products for wide range of clinical area including interventional cardiology; electrophysiology; cardiac rhythm management; interventional oncology; pain management; and more. The company operates through two financial business segments namely cardiovascular and endoscopy. The company provides interventional oncology related products under the cardiovascular business segment.
With its subsidiaries and network of distribution, the company has its presence across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The major subsidiaries of the company include Merit Medical GmbH (Germany), BioSphere Medical, Inc. (U.S.), Merit Medical Austria GmbH (Austria).
C.R. Bard, Inc.
Founded in 1907 and headquartered at New Jersey, the U.S.; C. R. Bard, Inc. is a developer, manufacturer, and marketer of Vascular, Urology, Oncology, and Surgical products. The company focuses on the development of single-patient-use medical products for hospital procedures and is dedicated to pursuing technological innovations to offer superior clinical benefits while helping to reduce overall health care costs. The company markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company provides interventional oncology products under the segment BD Interventional.
With its subsidiaries and strong network of distribution, the company has its presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In December 2017, the company was acquired by Becton, Dickinson and Company (U.S.). This acquisition expanded the product offering of Becton, Dickinson, and Company across the care continuum and offered growth opportunities for both the companies in non-U.S. markets.
Profound Medical Corp.
Incorporated in 2008 and headquartered at Mississauga, Canada; Profound Medical Corp. is a developer and manufacturer of therapeutic platform that provides the precision of real-time MR imaging combined with the safety and accuracy of directional (inside-out) and focused (outside-in) ultrasound technology for incision-free ablation of diseased tissue. The company serves wide range of customers, which includes academic/university/clinical leadership hospitals as well as private clinics with access to MRI scanners. The company relies on its strategic partners, including Koninklijke Philips N.V. (the Netherlands) and Siemens AG (Germany), for lead generation and distribution of the capital units.
With its subsidiaries and strong network of distribution, the company has its presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The major subsidiaries of the company include Profound Medical Inc. (Canada), Profound Medical Oy (Finland), Profound Medical GmbH (Germany), and Profound Medical (U.S.) Inc.
Meticulous Research in its latest publication on global Interventional Oncology Market has predicted the growth of 7.7% during the forecast year 2019 to 2025.
Founded in 1988 and headquartered at New York, the U.S.; AngioDynamics, Inc. is engaged in designing, manufacturing, and selling of medical, surgical and diagnostic devices. These devices are used by healthcare professionals for the treatment of peripheral vascular disease, vascular access, oncology, and surgical settings. Moreover, these products are applicable for minimally invasive and image guided procedures. The company operates through three business segments namely Peripheral Vascular (“PV”), Oncology/Surgery (“OS”) and Vascular Access (“VA”). The company offers interventional oncology products under Oncology/Surgery business segment.
With its subsidiaries and strong network of distribution, the company has its presence across North America and other regions. The subsidiaries of the company are Navilyst Medical (U.S.), Vortex Medical, Inc. (U.S.), and AngioDynamics UK Ltd. (U.K.).
Incorporated in 1991 and headquartered at London, the U.K.; BTG plc is a healthcare company focusing on interventional medicine. The company provides products for the treatment of cancer, vascular conditions and severe emphysema. The company operates its business through three segments namely Interventional Medicine, Pharmaceuticals, and Licensing. The company offers interventional oncology products specifically for embolization, ablation, and cryoablation therapies under interventional medicine segment.
With its subsidiaries and strong network of distribution, the company has its presence across North America, Europe, Asia, and Australia. Biocompatibles International plc (U.K.), Protherics Inc. (U.S.), and Galil Medical Ltd (Israel) are few subsidiaries of the company.
Founded in 1921 and headquartered at Tokyo, Japan; Terumo Corporation is engaged in manufacturing and selling of medical products and equipment, including pharmaceuticals, nutritional food supplement, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis products, blood glucose monitoring system, medical electronic, and digital thermometers. The company offers these products through three business segments namely Cardiac & Vascular Company, General Hospital Company, and Blood Management Company. The company provides interventional oncology products under Terumo Interventional Systems Division of Cardiac & Vascular Company business segment.
With its subsidiaries and strong network of distribution, the company has its presence across North America, Europe, Asia Pacific, and Rest of World. Terumo Medical Corporation (U.S.) and Terumo BCT, Inc. (U.S.) are few subsidiaries of the company.
Founded in 1949 and headquartered at Dublin, Ireland; Medtronic plc is engaged in developing and manufacturing medical technology, solutions, and services to reduce the pain with restoring health, and extending life for millions of people around the world. The company provides various medical products through four reportable segments namely Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The company offers interventional oncology products under minimally invasive therapies group business segment.
With its subsidiaries and strong network of distribution, the company has its presence across North America, Europe, Asia Pacific, and Rest of World. Covidien Ltd. (Ireland), Medtronic Limited (U.K.), Medtronic CoreValve LLC (U.S.) are few subsidiaries of the company.
Founded in 1989 and headquartered at Texas, the U.S.; HealthTronics, Inc. is engaged in providing integrated minimally invasive mobile technology-based products and services. The company offers lithotripsy, lasers, cryotherapy equipment, surgical nerve monitoring and microwave ablation as well as repair and maintenance services.
The company serves to hospitals and physicians. The company has healthcare facilities throughout the U.S. The company provides various products through its subsidiaries namely Endocare, Inc. (U.S.), Mobile Solutions, LLC (U.S.), and others.
Popular Mention: EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, and IMBiotechnologies Ltd.
Authoritative Research on the Interventional Oncology Market – Global Opportunity Analysis and Industry Forecast (2019-2025)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download report pages and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4951